Approved and Off-Label Uses of Obesity Medications, and Potential New Pharmacologic Treatment Options

Pharmaceuticals

Maria Luisa Isidro¹ 

[1] ndocrine Department, Complejo Hospitalario Universitario A Coruña As Xubias 84, 15006 A Coruña, Spain; E-Mail

关键词: obesity;    drug treatment;    orlistat;    sibutramine;    rimonabant;    leptin;    ghrelin;   

DOI  :  10.3390/ph3010125

来源: mdpi

【 摘 要 】

Available anti-obesity pharmacotherapy options remain very limited and development of more effective drugs has become a priority. The potential strategies to achieve weight loss are to reduce energy intake by stimulating anorexigenic signals or by blocking orexigenic signals, and to increase energy expenditure. This review will focus on approved obesity medications, as well as potential new pharmacologic treatment options.

【 授权许可】

CC BY   
© 2010 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland.